Myocardial infarction: etiology, clinical characteristics, myocardial biomarkers, pathophysiological and anatomical features based on clinical research and statistical analysis
Keywords:
Myocardial infarction, etiology, epidemiology, pathophysiology, coronary disease, ischemia, necrosis, statistics, mortality, anatomy, clinical research, cardiovascular, myocardial biomarkers.Abstract
Myocardial infarction (MI) is one of the most severe and clinically significant manifestations of ischemic heart disease and remains a leading cause of morbidity and mortality worldwide. This condition is fundamentally characterized by irreversible necrosis of cardiomyocytes resulting from prolonged ischemia, most commonly associated with acute obstruction of coronary blood flow. Over recent decades, large-scale epidemiological and clinical studies have provided deeper insights into the multifactorial etiology of myocardial infarction, the evolution of its clinical features, and the complexity of its pathophysiological mechanisms. This article presents a comprehensive scientific review based on statistical data, theoretical models, and findings from major clinical investigations related to myocardial infarction. The analysis encompasses etiological factors, global and regional incidence rates, disease prevalence and mortality trends, as well as characteristic structural and functional alterations of the myocardium. Myocardial biomarkers are biochemical substances released into the bloodstream following myocardial tissue injury and play a crucial role in the early detection and diagnosis of myocardial infarction. The principal myocardial biomarkers include troponin (I and T), creatine kinase MB fraction (CK-MB), myoglobin, and lactate dehydrogenase (LDH). Troponin demonstrates high sensitivity and specificity and is regarded as the gold standard for confirming myocardial infarction. The primary clinical significance of CK-MB lies in the detection of reinfarction. Myoglobin is the earliest marker to rise, although it lacks cardiac specificity. LDH is a late-rising biomarker and is currently used in limited clinical settings. Particular attention is given to the pathophysiological cascade linking coronary artery pathology with myocardial injury, as well as to cellular and tissue-level anatomical changes. By synthesizing data from peer-reviewed studies, meta-analyses, and large-scale investigations, this review provides an integrated and theoretically grounded understanding of myocardial infarction. The findings highlight the persistent burden of this disease on the global healthcare system and emphasize the importance of evidence-based preventive strategies, early diagnosis, and continuous scientific research in mitigating its adverse impact.
References
1. Braunwald, E. (2019). Heart disease: A textbook of cardiovascular medicine. Elsevier.
2. Thygesen, K., et al. (2018). Fourth universal definition of myocardial infarction. Circulation, 138(20), 618–651.
3. Ergashev, B. (2025). Advances in oral health: Prevention, treatment, and systemic implications. American Journal of Education and Learning, 3(3), 1108–1114.
4. World Health Organization. (2023). Cardiovascular diseases fact sheet.
5. Libby, P. (2021). Inflammation in atherosclerosis. Nature, 592(7855), 524–533.
7. Ergashev, B. (2023). Tish toshlari. Models and Methods for Increasing the Efficiency of Innovative Research, 1(2), 67–75.
8. Zarone, F., Ferrari, M., Mangano, F., Leone, R., & Sorrentino, R. (2016). “All-ceramic” restorations: Current concepts and clinical considerations. International Journal of Dentistry, 2016, 1–12. https://doi.org/10.1155/2016/1356806
9. Behr, M., Rosentritt, M., & Handel, G. (2003). Fiber-reinforced composite fixed partial dentures: A systematic review. International Journal of Prosthodontics, 16(3), 273–279.
10. Rosenstiel, S. F., Land, M. F., & Fujimoto, J. (2016). Contemporary fixed prosthodontics. Elsevier.
11. Ergashev, B., & Raxmonov, S. (2025). Transmission dynamics of tuberculosis: An epidemiological and biological perspective. Kazakh Journal of Ecosystem Restoration and Biodiversity, 1(1), 28–35.
12. Conrad, H. J., Seong, W. J., & Pesun, I. J. (2007). Current ceramic materials and systems with clinical recommendations: A systematic review. Journal of Prosthetic Dentistry, 98(5), 389–404. https://doi.org/10.1016/S0022-3913(07)60124-3
13. Ergashev, B. (2025). Psychological support for cancer patients. ИКРО журнал, 15(1), 164–167.
14. Ergashev, B., & Raxmonov, Sh. (2025). Oral trichomoniasis: Epidemiology, pathogenesis, and clinical significance. Kazakh Journal of Ecosystem Restoration and Biodiversity, 1(1), 19–27.
17. Ergashev, B. (2025). Optimizing non-removable orthodontic treatment through individualized therapeutic programs for irreversible malocclusions. Estestvennye nauki v sovremennom mire, 4(7), 60–62.
19. Ergashev, B. (2025). Jinsiy xromosomalarda genlarning anormal ko‘rinishi. Yangi davr ilm-fani: Respublika ilmiy-amaliy konferensiyasi, 1(1), 107–112.
20. Conrad, H. J., Seong, W. J., & Pesun, I. J. (2007). Current ceramic materials and systems. Journal of Prosthetic Dentistry, 98(5), 389–404.
21. Manicone, P. F., Rossi Iommetti, P., & Raffaelli, L. (2007). Zirconia ceramics. Journal of Dentistry, 35(11), 819–826.
22. Ergashev, B. J. O. (2025). Tish olish operatsiyasidan keyin yuzaga chiqishi mumkin bo‘lgan asoratlar. Zhurnal nauchnykh issledovaniy i ikh resheniy, 4(02), 421–426.
23. Berdaliyev, A. S., & Ergashev, B. J. O‘g‘li. (2025). Olib-qo‘yiladigan tish protezlari qo‘llanilgandan keyingi asoratlari va klinik belgilari, hamda zamonaviy davolash usullari. Research Focus, 4(6), 263–273.
24. Ergashev, B. J. (2025). Tish olish operatsiyasidan keyin yuzaga chiqishi mumkin bo‘lgan asoratlar. Журнал научных исследований и их решений, 4(2), 421–426.
25. Goodacre, C. J., Bernal, G., Rungcharassaeng, K., & Kan, J. Y. (2003). Clinical complications in fixed prosthodontics. Journal of Prosthetic Dentistry, 90(1), 31–41. https://doi.org/10.1016/S0022-3913(03)00214-2
26. Ergashev, B. J. (2025). To‘liq va qisman adentiya etiologiyasi va patogenezidagi muhim faktorlar. Is’hoqxon Ibrat Followers Journal, 1(1), 9–17.
27. Ergashev, B. J. O‘g‘li. (2025). Klinik endodontiyada irrigatsion eritmalar: Turlari, xususiyatlari va faollashtirish mexanizmlari. Research Focus, 4(5), 215–222.
28. Ergashev, B. (2025). Etiology and pathogenesis of hypertrophic pulpitis. Modern Science and Research, 4(6), 5–10.
29. Ergashev, B. (2025). Pulpitning etiologiyasi, patogenezi, morfologiyasi va klinik simptomlari. Modern Science and Research, 4(3), 829–838.
31. Ergashev, B. (2025). Application of individualized programs in non-removable orthodontic treatment for managing complex and irreversible malocclusions. Reshenie sotsialnykh problem v upravlenii i ekonomike, 4(7), 163–166.
32. Bekzod, E. (2025). Sirkon dioksid qoplamalari va materialining klinik laborator ahamiyati. Journal of Uzbekistan’s
34. Ergashev, B. (2025). Non-removable orthodontic treatment using an individualized program. Innovatsionnye issledovaniya v sovremennom mire, 4(18), 137–139.